Life Molecular Imaging

LMI is pleased to announce the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to [18F]PI-2620 Injection, an investigational PET imaging agent targeting tau neurofibrillary tangles. The Fast Track Designation has been granted for clinical development in Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD).   This designation underscores the significant potential of [18F]PI-2620 to improve diagnosis of these three devastating neurodegenerative diseases. In the words of Andrew Stephens, LMI's Chief Medical Officer, "We are committed to advancing this important imaging agent with the potential to make a meaningful difference for patients who need accurate and accessible Tau PET imaging.” Visit this link to learn more: https://lnkd.in/gjkjixMr #LMI #PETimaging #TauPETimaging #Alzeimersdisease #FDAFastTrackDesignation #ProgressiveSupranuclearPalsy #CorticobasalDegeneration

Raye LaPlante Jr, Margaret Cadden, Ph.D., & Karen Murray, SHRM-SCP visited the SOFIE radiopharmaceutical site in Haverhill, MA to learn more about the manufacturing process of Neuraceq®. A special shoutout to the SOFIE team in Haverhill for their time and effort. So much detail goes into this process and we're so grateful for our partnership!   For further details on Neuraceq® (florbetaben F 18 injection) in the US, please refer to the following prescribing information: https://lnkd.in/e5m6HC6m #Neuraceq #radiopharmaceuticals #nuclearmedicine #alzheimersdisease #LMI #SOFIE

Neuraceq® is now available in Denver, CO! LMI and PharmaLogic Holdings Corp. (PharmaLogic), a world-class contract development and manufacturing organization (CDMO) and radiopharmacy solutions provider, announce their new strategic partnership and licensing agreement to provide and distribute Neuraceq® from PharmaLogic’s radiopharmaceutical manufacturing site located near Denver, CO. The first doses have officially been made available! Read more about this exciting news here: https://lnkd.in/eEGrAuKw For further details on Neuraceq® (florbetaben F 18 injection) in the US, please refer to prescribing information here: https://lnkd.in/e5m6HC6m

LMI is hiring! Our CMC Project Management team is seeking a new CMC Project manager. The primary tasks in this exciting role include planning and executing the CMC strategy as well as responsibility for the set-up, oversight, and extension program of contract manufacturing sites and so much more. The position is based at our headquarters in Berlin, Germany. If you want to be part of an enthusiastic team of professionals, have a wide range of responsibilities and if your profile fits the description, please apply via the link below! https://lnkd.in/eunPRThk #LMI #WereHiring #CMC #CMCProjectManagement #ProjectManagement #healthcareindustry #nuclearmedicine #radiopharmaceuticals #molecularimaging #lifemolecularimaging

LMI welcomes Chris Winer, Key Account Manager serving the Rocky Mountain Territory in the US. Chris comes to us with 22 years of experience in the biotech/pharmaceutical space as a sole contributor, regional sales trainer, and regional sales manager. Chris was born and raised in New Jersey and currently resides in Colorado since 2014. He is a proud father of three teenage daughters, including twins.   Welcome to the team, Chris! We’re glad you joined us on our journey.   Learn about open positions at Life Molecular Imaging here: https://lnkd.in/dSyVHEw

Life Molecular Imaging (LMI) and The University of Wisconsin Alzheimer's Disease Research Center (ADRC) have entered a collaborative agreement to support the National Institute on Aging (NIA)-sponsored study titled “Consortium for Clarity in ADRD Research Through Imaging (CLARiTI)”.   This collaboration provides access for #CLARiTI investigators, spanning all 37 ADRCs in the United States, for both F 18 Florbetaben (Neuraceq®) Amyloid PET and PI-2620 Tau PET. In the words of LMI's Chief Medical Officer, Andrew Stephens, "We have entered a new era of Alzheimer’s research, and CLARiTI will help illuminate new avenues of understanding for this complex disease.”   Read more about this significant collaboration here: https://lnkd.in/eaSssm_6   For further details on Neuraceq® (florbetaben F 18 injection) in the US, please refer to the following prescribing information: https://lnkd.in/e5m6HC6m   #Alzheimersdisease #Florbetaben #Neuraceq #PI2620 #TauPET #AmyloidPET #LMI #ADRC #NIA

If you're here, visit us at #AAIC booth #725! Our team looks forward to talking with you about how amyloid PET imaging is essential to uncovering the full story of #AlzheimersDisease, and to confirm eligibility for new therapies.   #amyloidPETimaging #florbetaben #dementia #AAIC24

#LMI is thrilled to have a strong presence at AAIC 2024! Our team will be presenting cutting-edge research and innovative products through a series of talks and poster presentations. We invite you to explore the list of abstracts featuring our products and our leaders as speakers and authors. To learn more at AAIC, stop by our booth #725! #Alzheimersdisease #neurology #amyloidPETimaging #florbetaben #dementia #AAIC24

If you’re attending #AAIC from July 28 – August 1, 2024, visit LMI at booth #725! Learn about how, now more than ever, amyloid PET imaging is essential to uncover the full story of #AlzheimersDisease, and to confirm eligibility for new therapies.   #amyloidPETimaging #florbetaben #dementia #AAIC24

#LMI had a wonderful time at the Pacific Southwest Technologist Chapter #SNMMI Viva Las Vegas event this past weekend! Barbara J. Grabher BS, CNMT, RT(N), NCT, FSNMMI-TS presented on Beta Amyloid Tau and the Alzheimer’s Disease Cascade, and the Role of Molecular Imaging for the Nuclear Medicine Technologist, and Kathy Gundy and Ula Shair T. had fantastic conversations about #Neuraceq Amyloid PET Scans with many amazing technologists in the area. For further details on Neuraceq® (florbetaben F 18 injection) in the US, please refer to the following prescribing information: https://lnkd.in/e5m6HC6m #AmyloidPET #BetaAmyloidPET #BetaAmyloidTau #Alzheimersdisease #NuclearMedicine #MolecularImaging #Technologist #PacificSouthwest #VivaLasVegas